Literature DB >> 9264407

Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression.

G Finkenzeller1, A Sparacio, A Technau, D Marmé, G Siemeister.   

Abstract

Stimulation of NIH3T3 cells with platelet-derived growth factor (PDGF)-BB enhances expression of vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen and a key mediator of tumor angiogenesis. Here, we identified cis-acting VEGF promoter elements and trans-acting factors which are involved in PDGF-stimulated VEGF expression. By 5'-deletion and transient transfection analysis, a G + C-rich region at -85 to -50 of the human VEGF promoter was shown to be necessary and sufficient for both PDGF inducible and basal expression. The region contains three potential recognition sites for Sp1 transcription factors, which overlap with two Egr-1 sites. Mutations that abolish the ability of Sp1 to interact with the VEGF promoter element also abrogate expression induced by PDGF. Mutations of the potential Egr-1 binding sites did not affect PDGF responsiveness. Gel shift and antibody supershift analyses showed that Sp1 and Sp3 interact constitutively with the VEGF promoter element. Our data strongly suggest that enhanced VEGF gene expression in PDGF-induced NIH3T3 cells is mediated by Sp1 and/or Sp3 transcription factors bound to the -85 to -50 promoter region of the VEGF gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264407     DOI: 10.1038/sj.onc.1201219

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

Review 1.  Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions.

Authors:  Yong Qin; Laurence H Hurley
Journal:  Biochimie       Date:  2008-02-29       Impact factor: 4.079

2.  Curcumin decreases specificity protein expression in bladder cancer cells.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sudhakar Chintharlapalli; Sabitha Papineni; Roger Smith; Xiangrong Li; Stephen Safe
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

3.  Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins.

Authors:  Sudhakar Chintharlapalli; Sabitha Papineni; Syng-Ook Lee; Ping Lei; Un Ho Jin; Steven I Sherman; Libero Santarpia; Stephen Safe
Journal:  Mol Carcinog       Date:  2011-01-25       Impact factor: 4.784

4.  Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.

Authors:  Shinji Koyama; Hitoshi Takagi; Atsushi Otani; Hideyasu Oh; Kazuo Nishimura; Yoshihito Honda
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

5.  MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.

Authors:  Xiangrong Li; Susanne U Mertens-Talcott; Shu Zhang; Kyounghyun Kim; Judith Ball; Stephen Safe
Journal:  Endocrinology       Date:  2010-04-09       Impact factor: 4.736

6.  In vitro footprinting of promoter regions within supercoiled plasmid DNA.

Authors:  Daekyu Sun
Journal:  Methods Mol Biol       Date:  2010

7.  Sp1king out cancer (....and fibrosis?).

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-08-06       Impact factor: 5.782

8.  The transcription factor Net regulates the angiogenic switch.

Authors:  Hong Zheng; Christine Wasylyk; Abdelkader Ayadi; Joseph Abecassis; Jack A Schalken; Hermann Rogatsch; Nicolas Wernert; Sauveur-Michel Maira; Marie-Christine Multon; Bohdan Wasylyk
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

9.  Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.

Authors:  Nabendu Pore; Shuang Liu; Hui-Kuo Shu; Bin Li; Daphne Haas-Kogan; David Stokoe; Julie Milanini-Mongiat; Gilles Pages; Donald M O'Rourke; Eric Bernhard; Amit Maity
Journal:  Mol Biol Cell       Date:  2004-09-01       Impact factor: 4.138

Review 10.  Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.

Authors:  N S Brown; R Bicknell
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.